HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

alpha-Internexin expression identifies 1p19q codeleted gliomas.

AbstractBACKGROUND:
alpha-Internexin (INA) is a proneural gene encoding a neurofilament interacting protein that is upregulated in some gliomas, particularly oligodendrogliomas.
METHODS:
INA expression was evaluated by immunohistochemistry in a series of 122 gliomas, and correlated to the 1p19q codeletion, a favorable prognostic marker of oligodendroglial tumors.
RESULTS:
INA expression was strong (>10% positive cells) in 22 cases (22 oligodendroglial tumors and 0 astrocytic tumors), weak (<10% cells) in 14 cases (12 oligodendroglial tumors, 2 glioblastoma with an oligodendroglial component, and 0 astrocytic tumors), and negative in 86 cases (49 oligodendroglial tumors, 9 glioblastoma with an oligodendroglial component, and 28 astrocytic tumors). Among the 27 tumors exhibiting the 1p19q codeletion (all with an oligodendroglial phenotype), INA was detected in 96% (26/27, 18 strong, 8 weak) as compared to 11% (10/95, 4 strong, 6 weak) in the tumors without 1p19q codeletion (with an oligodendroglial or an astrocytic phenotype) (p < 0.001). In oligodendroglial tumors, INA expression specificity for 1p19q codeletion was 86%, sensitivity 96%, positive predictive value 76%, and negative predictive value was 98%. The prognostic impact of INA expression could be evaluated in grade III oligodendroglial tumors. Similar to 1p19q deletion, positive INA expression was correlated with better progression-free survival (52.6 vs 8.7 months [p = 0.001]) and overall survival (121.1 vs 31.4 months [p = 0.0001]).
CONCLUSION:
alpha-Internexin (INA) expression appears to be a simple, reliable prognostic marker and a surrogate marker of 1p19q codeletion.
AuthorsF Ducray, E Crinière, A Idbaih, K Mokhtari, Y Marie, S Paris, S Navarro, F Laigle-Donadey, C Dehais, J Thillet, K Hoang-Xuan, J-Y Delattre, M Sanson
JournalNeurology (Neurology) Vol. 72 Issue 2 Pg. 156-61 (Jan 13 2009) ISSN: 1526-632X [Electronic] United States
PMID19139367 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Intermediate Filament Proteins
  • alpha-internexin
Topics
  • Brain Neoplasms (diagnosis, genetics)
  • Chromosomes, Human, Pair 1 (genetics)
  • Chromosomes, Human, Pair 19 (genetics)
  • DNA Mutational Analysis
  • Disease Progression
  • Gene Deletion
  • Genes
  • Genetic Predisposition to Disease (genetics)
  • Genetic Testing
  • Genotype
  • Glioma (diagnosis, genetics)
  • Humans
  • Intermediate Filament Proteins (genetics)
  • Mutation (genetics)
  • Oligodendroglioma (diagnosis, genetics)
  • Predictive Value of Tests
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: